On a consolidated basis, Infosys' net profit declined 2.1% to Rs 3612 crore on 5.8% rise in revenues to Rs 19128 crore in Q1 June 2018 over Q4 March 2018. Financial year ending March 2018 revenue guidance in constant currency was retained at 6%-8%, while operating margin guidance was retained at 22%-24%. The result was announced after market hours on Friday, 13 July 2018.
Infosys board of directors also considered, approved and recommended a bonus issue of one equity share for every equity share held and a stock dividend of one American Depositary Share (ADS) for every ADS held, as on a record date to be determined.
Aurobindo Pharma announced the signing of a definitive agreement to acquire from Apotex International Inc. (Apotex), its commercial operations and certain supporting infrastructure in five European countries. The acquisition is in line with Aurobindo's strategy to strengthen and grow its European business and to expand in Eastern Europe. The announcement was made on Saturday, 14 July 2018.
Bajaj Corp's net profit declined 2.2% to Rs 53.77 crore on 6.76% rise in total income to Rs 222.58 crore in Q1 June 2018 over Q1 June 2017. The result was announced after market hours on Friday, 13 July 2018.
CCL Products (India) consolidated net profit rose 45.93% to Rs 39.46 crore on 18.23% rise in total income to Rs 294.77 crore in Q1 June 2018 over Q1 June 2017. The result was announced on Saturday, 14 July 2018.
Just Dial scheduled a board meeting on 20 July 2018 consider and approve the proposal to buy-back fully paid-up equity shares of the company. The announcement was made after market hours on Friday, 13 July 2018.
0 thoughts on “Infosys in focus after Q1 result, bonus issue”